|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C40B 30/04 | (2006.01) |
| G01N 33/574 | (2013.01) | ||
| G01N 33/574 | (2006.01) | ||
| G01N 33/57492 | (2013.01) | ||
| G01N2333/70596 | (2013.01) | ||
| G01N2800/52 | (2013.01) | ||
| C40B 30/04 | (2013.01) | ||
| G01N2500/02 | (2013.01) |
| (11) | Patento numeris | 3802922 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19740098.9 |
| Europos patento paraiškos padavimo data | 2019-06-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-04-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-04-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2019/036252 |
| Data | 2019-06-10 |
| (87) | Numeris | WO 2019/241098 |
| Data | 2019-12-19 |
| (30) | Numeris | Data | Šalis |
| 201862683256 P | 2018-06-11 | US |
| (72) |
BLAIR, David A. , US
CHEN, Lieping , US
WANG, Jun , US
ZHENG, Timothy , US
|
| (73) |
Yale University ,
2 Whitney Avenue, New Haven, CT 06510,
US
Boehringer Ingelheim International GmbH , Binger Strasse 173, 55216 Ingelheim am Rhein, DE |
| (54) | NOVEL IMMUNE CHECKPOINT INHIBITORS |
| NOVEL IMMUNE CHECKPOINT INHIBITORS |